L1CAM and neoplasm: We previously developed a fully human anti-L1CAM mAb (Ab417, IgG1) that cross-reacts with mouse L1CAM, and validated that Ab417 inhibits tumor growth in a Choi-CK xenograft nude mouse model [27].